The popular GLP-1 weight-loss drug will be available via a subscription program designed to lower costs for self-pay patients ...

Foundayo is the first oral GLP-1 weight loss pill that doesn't require fasting.

Eli Lilly's new weight-loss pill, sold under the name Foundayo, gives consumers a second option for a non-injectable GLP-1.

The FDA approved Wegovy HD, a higher-dose semaglutide for weight loss in adults with obesity, offering greater weight ...

A UAB-developed automated online weight loss program helps cancer survivors achieve the highest weight loss ever reported for a digital intervention, improving cardiometabolic health, diet quality and ...

The Trump administration has secured pricing agreements with major drugmakers to lower GLP-1 weight loss drug costs to ...

A new program helps patients safely transition off GLP-1 medications while maintaining results through nutrition, ...

Eli Lilly's new daily pill GLP-1 moved through the FDA approval process faster after the FDA's new review and approval process.

This week the U.S. Food and Drug Administration approved a second GLP-1 pill for weight loss. The drug, called Foundayo, ...

Weight-loss clinics have opened at a steady pace across upstate New York over the past few years. From Geneva to Canandaigua, more residents are turning to medically supervised programs for help with ...

When people who are overweight and obese stopped taking their weight-loss medications they regained weight faster than those who stopped a diet or exercise program, a new review has found. Weight loss ...

Shed pounds and move better than ever. All you have to do is take a first step.